Profile picture

Doctor Deniz Akdis

University Heart Center, Zurich (Switzerland)
Follow
Logo ESC

Contributor content

Sex differences in metabolic and inflammatory profiles in arrhythmogenic cardiomyopathy: insights from myocardial and plasma omics
Presentation
Sex differences in metabolic and inflammatory profiles in arrhythmogenic cardiomyopathy: insights from myocardial and plasma omics
Inflammation and Fibrosis Markers Predict Adverse Outcomes in Arrhythmogenic Cardiomyopathy: An Integrated Multiomics Study
Presentation
Inflammation and Fibrosis Markers Predict Adverse Outcomes in Arrhythmogenic Cardiomyopathy: An Integrated Multiomics Study
Integrated plasma proteomics and myocardial tissue transcriptomics reveal elevated fibrosis markers in arrhythmogenic cardiomyopathy patients
Presentation
Integrated plasma proteomics and myocardial tissue transcriptomics reveal elevated fibrosis markers in arrhythmogenic cardiomyopathy patients
Identifying proteomic profiles as indicators of disease severity in arrhythmogenic cardiomyopathy
Presentation
Identifying proteomic profiles as indicators of disease severity in arrhythmogenic cardiomyopathy
Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement
Presentation
Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement
Left ventricular dysfunction in arrhythmogenic cardiomyopathy: the influence of genotype, exercise and biomarkers
Presentation
Left ventricular dysfunction in arrhythmogenic cardiomyopathy: the influence of genotype, exercise and biomarkers
Identification of novel biomarkers for diagnosis of arrhythmogenic right ventricular cardiomyopathy using transcriptomics and label-free proteomics
Presentation
Identification of novel biomarkers for diagnosis of arrhythmogenic right ventricular cardiomyopathy using transcriptomics and label-free proteomics
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome
Presentation
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome
Association between genotype and long-term outcome of ventricular involvement patterns in arrhythmogenic right ventricular cardiomyopathy/dysplasia
Presentation
Association between genotype and long-term outcome of ventricular involvement patterns in arrhythmogenic right ventricular cardiomyopathy/dysplasia
Elevated testosterone serum levels contribute to adverse outcome in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia
Presentation
Elevated testosterone serum levels contribute to adverse outcome in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia

ESC 365 is supported by